Screener
Phathom Pharmaceuticals, Inc. PHAT Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue, net | $74,274 | $39,503 | $132,575 | $68,023 |
| Cost of revenue | 15,096 | 5,038 | 27,091 | 8,762 |
| Gross profit | 59,178 | 34,465 | 105,484 | 59,261 |
| Operating expenses: | ||||
| Research and development | 7,813 | 9,076 | 15,585 | 18,260 |
| Selling, general and administrative | 55,330 | 85,313 | 109,341 | 179,787 |
| Total operating expenses | 63,143 | 94,389 | 124,926 | 198,047 |
| Loss from operations | (3,965) | (59,924) | (19,442) | (138,786) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s total cost of revenue?
- Phathom Pharmaceuticals, Inc. (PHAT) reported total cost of revenue of $15.1M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s total cost of revenue increased by 199.6% year-over-year, from $5.04M to $15.1M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Phathom Pharmaceuticals, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude